A Buntinx
Overview
Explore the profile of A Buntinx including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
De Schepper P, Imperato-McGinley J, Van Hecken A, De Lepeleire I, Buntinx A, Carlin J, et al.
Steroids
. 1991 Sep;
56(9):469-71.
PMID: 1666698
The hormonal effects following the acute (single dose) administration of a 4-azasteroid inhibitor of 5 alpha-reductase (MK-906) were evaluated in 10 healthy male volunteers. Marked suppression of serum dihydrotestosterone (DHT)...
12.
de Jong E, van Vlijmen I, Scholte J, Buntinx A, Friedman B, Tanaka W, et al.
Skin Pharmacol
. 1991 Jan;
4(4):278-85.
PMID: 1724166
Antipsoriatic agents have been shown to decrease skin levels of arachidonic acid and its metabolites including 12-monohydroxy-eicosatetranoic acid (12-HETE), and leukotriene B4 (LTB4). In addition, specific systemic and topical lipoxygenase...
13.
Vermeulen A, Giagulli V, De Schepper P, Buntinx A
Eur Urol
. 1991 Jan;
20 Suppl 1:82-6.
PMID: 1722168
Finasteride is a potent competitive 5 alpha-reductase inhibitor, active at a dose as low as 1 mg/day. After a single dose, the effects on 5 alpha-reductase last as long as...
14.
De Lepeleire I, Van Hecken A, Verbesselt R, Buntinx A, Distlerath L, De Schepper P
Int J Clin Pharmacol Res
. 1990 Jan;
10(3):167-71.
PMID: 2228341
In eight healthy male volunteers taking daily subtherapeutic doses of warfarin (mean daily dose = 4.0 mg), the addition of famotidine 40 mg once-a-day for seven days did not alter...
15.
Vermeulen A, Giagulli V, De Schepper P, Buntinx A, Stoner E
Prostate
. 1989 Jan;
14(1):45-53.
PMID: 2538808
The objective of this study was to estimate the minimum in vivo effective oral dose and duration of action of the competitive 5 alpha-reductase inhibitor MK-906, a 4-azasteroid, in humans....
16.
van Hecken A, Verbesselt R, Buntinx A, CIRILLO V, De Schepper P
Br J Clin Pharmacol
. 1987 Jan;
23(1):84-7.
PMID: 3028456
Single doses of enalapril maleate 10 mg and frusemide 80 mg do not significantly affect the pharmacokinetics of each other when taken concomitantly. Their concomitant use may be associated with...
17.
Tobert J, Bell G, Birtwell J, James I, Kukovetz W, PRYOR J, et al.
J Clin Invest
. 1982 Apr;
69(4):913-9.
PMID: 6918402
Mevinolin reduces cholesterol synthesis by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A reductase. The safety and effectiveness of this agent was evaluated in a double-blind, placebo-controlled study in 59 healthy men (serum cholesterol 3.88--7.76...
18.
Tobert J, CIRILLO V, Hitzenberger G, James I, Pryor J, Cook T, et al.
Clin Pharmacol Ther
. 1981 Mar;
29(3):344-50.
PMID: 7471605
Racemic indacrinone is a high-ceiling, relatively long-acting diuretic. Both enantiomers have uricosuric activity, but the diuretic activity resides predominantly in the (-) enantiomer. Usual therapeutic doses of racemic indacrinone have...
19.
Verbeeck R, Boel A, Buntinx A, De Schepper P
Biochem Pharmacol
. 1980 Feb;
29(4):571-6.
PMID: 7370051
No abstract available.